The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate
The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate
Perioperative bleeding is the most common complication related to transurethral resection of
 prostate, the aim of the study is to compare the effect of pre-operative use of finasteride
 versus Cyproterone acetate on blood loss with mono polar TURP
This prospective randomized controlled study to compare the effect of pre-operative use of
 finasteride versus Cyproterone acetate on blood loss with mono polar TURP
Inclusion Criteria:

 -  Patients with benign prostatic hyperplasia with prostate size (60-100) grams

 -  Lower urinary tract symptoms (LUTS) not responding to medical treatment

 -  Recurrent prostatic bleeding

 -  Recurrent acute urinary retention

 -  Chronic urinary retention

 Exclusion Criteria:

 -  Patients with coagulation disorders

 -  Previous prostatic surgery

 -  Previous finasteride administration

 -  Bladder pathology (urinary bladder stones - bladder mass)

 -  Suspected or proved cancer prostate

 -  Hepatic or renal impairment

 -  Patients unfit for operation eg. Decompensated heart failure, poor chest condition